
Josh Jennings
Stock Analyst at TD Cowen
(4.13)
# 1,648
Out of 5,136 analysts
1177
Total ratings
46.6%
Success rate
5.3%
Average return
Main Sectors:
Stocks Rated by Josh Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCEL AVITA Medical | Reiterated: Buy | $14 → $22 | $15.22 | +44.55% | 37 | Nov 12, 2026 | |
| HUMA Humacyte | Reiterated: Buy | $1.25 | $0.5403 | +131.35% | 49 | Nov 11, 2026 | |
| STXS Stereotaxis | Reiterated: Buy | $3 → $2 | $0.8027 | +149.16% | 31 | Nov 11, 2026 | |
| SENS Senseonics Holdings | Reiterated: Buy | $15 → $17 | $10.90 | +55.96% | 17 | Nov 10, 2026 | |
| AVR Anteris Technologies Global | Reiterated: Buy | $15 | $5.70 | +163.16% | 12 | Nov 6, 2026 | |
| VCEL Vericel | Reiterated: Buy | $58 → $63 | $57.48 | +9.60% | 26 | Nov 6, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $104 → $117 | $107.11 | +9.23% | 74 | Nov 5, 2026 | |
| OM Outset Medical | Reiterated: Buy | $10 | $3.39 | +194.99% | 31 | Nov 5, 2026 | |
| PRCT PROCEPT BioRobotics | Reiterated: Buy | $28 | $23.54 | +18.95% | 32 | Nov 5, 2026 | |
| BDX Becton, Dickinson and Company | Reiterated: Hold | $182 | $216.47 | -15.92% | 24 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.86 | +168.82% | 39 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $92.21 | +30.14% | 75 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $56 → $46 | $43.69 | +5.29% | 84 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $81.61 | +16.41% | 43 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $69.82 | +36.06% | 58 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $135 → $118 | $107.45 | +9.82% | 78 | Oct 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.71 | +75.13% | 35 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 → $33 | $26.42 | +24.91% | 25 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $102.88 | +6.92% | 75 | Sep 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $7.12 | +110.67% | 5 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $13.55 | +84.50% | 31 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $29 | $25.54 | +13.55% | 39 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 | $282.55 | -11.52% | 44 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $20 | $6.78 | +194.99% | 27 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $379 | $145.29 | +160.86% | 23 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.0033 | n/a | 10 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $435 | $310.72 | n/a | 40 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $0.0021 | n/a | 12 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $18.48 | n/a | 23 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $104 → $99 | $101.41 | n/a | 33 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.55 | n/a | 14 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.85 | n/a | 9 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25.66 | $10.44 | n/a | 5 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $13 | $0.8229 | n/a | 3 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $167.58 | n/a | 3 | Oct 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $400 | $0.0002 | n/a | 6 | Nov 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $3.5 | $0.773 | n/a | 2 | Sep 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.75 | $0.0001 | n/a | 1 | Aug 10, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $4.48 | n/a | 1 | Mar 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3.5 | $0.0001 | n/a | 1 | Aug 30, 2013 |
AVITA Medical
Nov 12, 2026
Reiterated: Buy
Price Target: $14 → $22
Current: $15.22
Upside: +44.55%
Humacyte
Nov 11, 2026
Reiterated: Buy
Price Target: $1.25
Current: $0.5403
Upside: +131.35%
Stereotaxis
Nov 11, 2026
Reiterated: Buy
Price Target: $3 → $2
Current: $0.8027
Upside: +149.16%
Senseonics Holdings
Nov 10, 2026
Reiterated: Buy
Price Target: $15 → $17
Current: $10.90
Upside: +55.96%
Anteris Technologies Global
Nov 6, 2026
Reiterated: Buy
Price Target: $15
Current: $5.70
Upside: +163.16%
Vericel
Nov 6, 2026
Reiterated: Buy
Price Target: $58 → $63
Current: $57.48
Upside: +9.60%
Edwards Lifesciences
Nov 5, 2026
Reiterated: Buy
Price Target: $104 → $117
Current: $107.11
Upside: +9.23%
Outset Medical
Nov 5, 2026
Reiterated: Buy
Price Target: $10
Current: $3.39
Upside: +194.99%
PROCEPT BioRobotics
Nov 5, 2026
Reiterated: Buy
Price Target: $28
Current: $23.54
Upside: +18.95%
Becton, Dickinson and Company
Nov 4, 2026
Reiterated: Hold
Price Target: $182
Current: $216.47
Upside: -15.92%
Nov 3, 2026
Reiterated: Buy
Price Target: $5
Current: $1.86
Upside: +168.82%
Nov 2, 2026
Reiterated: Buy
Price Target: $120
Current: $92.21
Upside: +30.14%
Oct 30, 2026
Downgraded: Hold
Price Target: $56 → $46
Current: $43.69
Upside: +5.29%
Oct 30, 2026
Reiterated: Buy
Price Target: $95
Current: $81.61
Upside: +16.41%
Oct 30, 2026
Reiterated: Buy
Price Target: $95
Current: $69.82
Upside: +36.06%
Oct 22, 2026
Rated: Buy
Price Target: $135 → $118
Current: $107.45
Upside: +9.82%
Oct 7, 2026
Reiterated: Buy
Price Target: $10
Current: $5.71
Upside: +75.13%
Oct 2, 2026
Rated: Buy
Price Target: $29 → $33
Current: $26.42
Upside: +24.91%
Sep 30, 2026
Reiterated: Buy
Price Target: $110
Current: $102.88
Upside: +6.92%
Sep 25, 2026
Reiterated: Buy
Price Target: $15
Current: $7.12
Upside: +110.67%
Sep 24, 2026
Reiterated: Buy
Price Target: $25
Current: $13.55
Upside: +84.50%
Jul 31, 2026
Reiterated: Hold
Price Target: $24 → $29
Current: $25.54
Upside: +13.55%
Apr 23, 2026
Reiterated: Buy
Price Target: $250
Current: $282.55
Upside: -11.52%
Jan 23, 2026
Reiterated: Buy
Price Target: $27 → $20
Current: $6.78
Upside: +194.99%
Dec 4, 2025
Reiterated: Buy
Price Target: $379
Current: $145.29
Upside: +160.86%
Nov 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $0.0033
Upside: n/a
Nov 13, 2025
Reiterated: Buy
Price Target: $435
Current: $310.72
Upside: n/a
Nov 12, 2025
Reiterated: Buy
Price Target: $90
Current: $0.0021
Upside: n/a
Nov 6, 2025
Reiterated: Buy
Price Target: $20
Current: $18.48
Upside: n/a
Nov 5, 2025
Reiterated: Hold
Price Target: $104 → $99
Current: $101.41
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $2.55
Upside: n/a
Jan 12, 2024
Rated: Hold
Price Target: n/a
Current: $4.85
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: $25.66
Current: $10.44
Upside: n/a
Mar 4, 2022
Reiterated: Buy
Price Target: $15 → $13
Current: $0.8229
Upside: n/a
Oct 29, 2020
Reiterated: Buy
Price Target: $80
Current: $167.58
Upside: n/a
Nov 9, 2018
Reiterated: Buy
Price Target: $11 → $400
Current: $0.0002
Upside: n/a
Sep 27, 2018
Reiterated: Buy
Price Target: $17 → $3.5
Current: $0.773
Upside: n/a
Aug 10, 2017
Reiterated: Buy
Price Target: $0.75
Current: $0.0001
Upside: n/a
Mar 18, 2015
Reiterated: Buy
Price Target: $9
Current: $4.48
Upside: n/a
Aug 30, 2013
Initiated Coverage: Buy
Price Target: $3.5
Current: $0.0001
Upside: n/a